Johnson & Johnson Sees Mixed Unusual Options Activity as Stock Slides Near 52-Week High

By TrendSpider Editor

Johnson & Johnson attracted unusual options activity on Thursday, August 27, 2026, with three notable contracts totaling $1,081,900 in combined premium as shares slipped 1.03% to $267.27. The largest single contract was a $160,000 in-the-money put at the $270 strike expiring tomorrow, signaling near

Johnson & Johnson Sees Mixed Unusual Options Activity as Stock Slides Near 52-Week High

Johnson & Johnson attracted unusual options activity on Thursday, August 27, 2026, with three notable contracts totaling $1,081,900 in combined premium as shares slipped 1.03% to $267.27. The largest single contract was a $160,000 in-the-money put at the $270 strike expiring tomorrow, signaling near-term caution from at least one large player. Despite today's pullback, JNJ remains well positioned within its 52-week range of $173.33 to $276.47, trading close to its annual highs.

Key Drivers of the JNJ Stock Move

• Main Catalyst: Three unusual options contracts were flagged today with a combined premium of $1,081,900. Activity included a $160,000 in-the-money put at the $270 strike expiring August 28, a $43,400 in-the-money call at the $255 strike expiring September 4, and an $878,500 out-of-the-money call at the $270 strike expiring November 20. The largest premium flow by far was on the longer-dated call position.
• Bull Case: The dominant contract by premium is the November 20 $270 call, which carries $878,500 in premium and printed at 310% of open interest, suggesting a high-conviction, directional bet that JNJ breaks back above $270 before year-end. The September 4 $255 call printing at 800% of open interest, while smaller in dollar terms, also points to a cluster of bullish positioning deeper in the money.
• Bear Case: The in-the-money $270 put expiring tomorrow represents immediate downside hedging or outright bearish speculation. With JNJ at $267.27 and already below that strike, the position is profitable as-is, and with only one trading day left until expiration, it reflects a pointed near-term bearish view. The stock's 1.03% decline today adds weight to this short-term caution.

Looking ahead, the options tape tells a somewhat split story. The near-term put activity suggests some traders expect continued softness into Friday's close, while the bulk of premium committed, nearly $878,500, is positioned for a recovery and push above $270 by late November. JNJ is trading roughly $9 below its 52-week high of $276.47, so the bulls in the November contract are betting on a relatively modest move from current levels. The stock's elevated position within its annual range suggests the underlying trend remains constructive, but traders are clearly hedging around short-term volatility.

JNJ Unusual Options Activity

• Contract 1: Put | Strike: $270 | Expiry: August 28, 2026 | Size: 500 | Open Interest: 28% | Status: In the Money | Premium: $160,000
• Contract 2: Call | Strike: $255 | Expiry: September 4, 2026 | Size: 40 | Open Interest: 800% | Status: In the Money | Premium: $43,400
• Contract 3: Call | Strike: $270 | Expiry: November 20, 2026 | Size: 700 | Open Interest: 310% | Status: Out of the Money | Premium: $878,500

All three contracts were flagged as unusual based on their size relative to open interest. The September 4 call printing at 800% of open interest is the most statistically anomalous, though the November call commands the most capital commitment of the three.

JNJ Seasonality

Late August and early September have historically been a mixed period for large-cap healthcare names, as investors position ahead of fall medical conferences and any pipeline announcements. The presence of both near-term hedges and longer-dated bullish calls may reflect awareness of potential catalysts on the horizon before the November expiration.

JNJ Relative Performance

JNJ's 1.03% decline today is a modest pullback for a stock that has climbed significantly from its 52-week low of $173.33, with the current price of $267.27 representing a gain of roughly 54% from that trough level over the past year. The stock sits approximately 3.3% below its 52-week high of $276.47, reflecting relative strength against broader market benchmarks even with today's slip.